搜索筛选:
搜索耗时0.6228秒,为你在为你在102,267,441篇论文里面共找到 11 篇相符的论文内容
发布年度:
PhaseⅠdose-finding study of sorafenib with FOLFOX4 as firstline treatment in patients with unresecta
[期刊论文] 作者：Yihebali Chi,
来源：中国癌症研究：英文版 年份：2015
Objective: To determine the maximum tolerated dose(MTD), dose-limiting toxicity(DLT) and efficacy of sorafenib in combination with FOLFOX4(oxaliplatin/leucovori...
[期刊论文] 作者：Yihebali Chi,Feng Du,Hong Zhao,
来源：世界胃肠病学杂志：英文版（电子版） 年份：2014
AIM:To analyze the clinicopathologic characteristics and prognostic factors of rectal neuroendocrine tumors.METHODS:The records of 48 patients with rectal neuro...
[期刊论文] 作者：Yihebali Chi,Feng Du,Hong Zhao,Jin-Wan Wang,Jian-Qiang Cai,,
来源：World Journal of Gastroenterology 年份：2014
AIM:To analyze the clinicopathologic characteristics and prognostic factors of rectal neuroendocrine tumors.METHODS:The records of 48 patients with rectal neuro...
Phase Ⅰ dose-finding study of sorafenib with FOLFOX4 as first-line treatment in patients with unrese
[期刊论文] 作者：Yihebali Chi,Jianliang Yang,Sheng Yang,Yongkun Sun,Bo Jia,Yuankai Shi,
来源：中国癌症研究（英文版） 年份：2015
...
[期刊论文] 作者：Yihebali Chi,REN Jian-hong,YANG Lin,CUI Cheng-xu,LI Jun-ling,WANG Jin-wan,
来源：中华医学杂志英文版 年份：2011
...
PhaseⅠdose-finding study of sorafenib with FOLFOX4 as firstline treatment in patients with unresecta
[期刊论文] 作者：Yihebali Chi,Jianliang Yang,Sheng Yang,Yongkun Sun,Bo Jia,Yuankai Shi,,
来源：Chinese Journal of Cancer Research 年份：2015
Objective: To determine the maximum tolerated dose(MTD), dose-limiting toxicity(DLT) and efficacy of sorafenib in combination with FOLFOX4(oxaliplatin/leucovori...
Efficacy and toxicity of capecitabine combined with intensitymodulated radiotherapy after D1/D2 lymp
[期刊论文] 作者：,Yong-Wen Song,Yue-Ping Liu,Yuan Tang,Ning Li,Wen-Yang Liu,Hui Fang,Ye-Xiong Li,Dong-Bing Zhao,Yihebali Chi,
来源：世界胃肠肿瘤学杂志:英文版(电子版) 年份：2021
BACKGROUND Adjuvant chemoradiotherapy(ACRT)with oral capecitabine and intensitymodulated radiotherapy(IMRT)were well tolerated in a phase I study in patients who had undergone partial or total gastrectomy for locally advanced gastric cancer......
A Randomized Phase Ⅱ Trial of Neoadjuvant Chemotherapy Compared with Chemoradiotherapy inLocally Adv
[会议论文] 作者：Xin Wang,Jing Jin,Dong-Bing Zhao,Yihebali Chi,Lin Yang,Li-Ming Jiang,Jun Jiang,Li-Zhou Dou,Yuan Tang,,
来源：2016年北京市肿瘤放疗年会 年份：2016
...
Efficacy and safety of regorafenib (REG) monotherapy in Chinese patients with previously treated met
[会议论文] 作者：Ruihua Xu,Jin Li,Thomas CC Yau,Brigette Ma,Hongming Pan,Jianming Xu,Yuxian Bai,Yihebali Chi,Liwei Wang,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective: The new oral multi-kinase inhibitor REG improves overall survival (OS) in mCRC patients who progress after standard therapies.CONCUR (NCT01584830) evaluated the efficacy and safety of REG i...
[期刊论文] 作者：Ning Li,Xin Wang,Yuan Tang,Dongbin Zhao,Yihebali Chi,Lin Yang,Liming Jiang,Jun Jiang,Jinming Shi,Wenyang,
来源：中国癌症研究（英文版） 年份：2021
Objective:The predictive effect of preoperative chemoradiotherapy(CRT)is low and difficult in guiding individualized treatment.We examined a surrogate endpoint for long-term outcomes in locally advanced gastric cancer patients after preoper......
[期刊论文] 作者：Ning Li,Xin Wang,Yuan Tang,Dongbin Zhao,Yihebali Chi,Lin Yang,Liming Jiang,Jun Jiang,Jinming Shi,Wenyang,
来源：中国癌症研究:英文版 年份：2021
Objective:The predictive effect of preoperative chemoradiotherapy(CRT)is low and difficult in guiding individualized treatment.We examined a surrogate endpoint for long-term outcomes in locally advanced gastric cancer patients after preoper......
相关搜索：
